Second primary malignancies in patients with Carcinoma of the kidney: A hospital based study

Journal of Medical Sciences

Volumn 30, Issue 5, 2010, Pages 199-206

  Lin, Yu Chun ^a   Ho, Jar Yi ^b   Cha, Tai Lung ^a   Chen, An ^a   Su, Sui Lung ^c   Yu, Cheng Ping ^a  

^a TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^b Graduate Institute of Life Sciences at TKU   (Taiwan)

^c NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

Author keywords

Carcinoma; Kidney; Second primary malignancies

Indexed keywords

ADULT; AGE; AGED; ARTICLE; BILE DUCT CARCINOMA; BLADDER CANCER; BLADDER CARCINOMA; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER GRADING; CANCER RADIOTHERAPY; CANCER RISK; CANCER STAGING; CLEAR CELL CARCINOMA; COLON CANCER; DIGESTIVE SYSTEM CANCER; DISEASE ASSOCIATION; ESOPHAGUS CANCER; FEMALE; GENDER; GENERAL HOSPITAL; HEAD AND NECK CANCER; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KIDNEY CANCER; KIDNEY CARCINOMA; LIVER CANCER; LIVER CELL CARCINOMA; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MULTIPLE CANCER; NASOPHARYNX CANCER; NEPHRECTOMY; OVARY CANCER; OVERALL SURVIVAL; PANCREAS ADENOCARCINOMA; PANCREAS CANCER; PAPILLARY CARCINOMA; PAROTID GLAND CANCER; PROSTATE CANCER; RECTUM CANCER; RECTUM CARCINOMA; RETROSPECTIVE STUDY; RISK FACTOR; SECOND CANCER; SKIN CANCER; STOMACH ADENOCARCINOMA; STOMACH CANCER; THYMUS CANCER; URETER CANCER; UROTHELIAL CELL CARCINOMA; UTERINE CERVIX ADENOCARCINOMA; UTERINE CERVIX CANCER;

EID: 78149386932     PISSN: 10114564     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Lindblad, P, Adami H.O, Kidney Cancer, in Textbook of Cancer Epidemiology, 2002, New York: Oxford University Press. 467-485.
2. Storkel S, Eble, JN, Adlakha K, Amin M, Blute ML, Bostwick DG, Darson M, Delahunt B, Iczkowski K. Classifi cation of renal cell carcinoma: workgroup No. 1. Union Internationale Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC). Cancer 1997;80:987-989.
3. Thompson RH, Leibovich BC, Cheville JC, Webster WS, Lohse CM, Kwon ED, Zincke H, Blute ML. Second primary malignancies associated with renal cell carcinoma histological subtypes. J Urol 2006;176:900-903.
4. Rabbani F, Reuter VE, Katz J, Russo P. Second primary malignancies associated with renal cell carcinoma: influence of histologic type. Urology 2000;56:399-403.
5. Jensen OM, Knudsen JB, Sorensen BL. Second cancer following cancer of the urinary system in Denmark, 1943-80. Natl Cancer Inst Monogr 1985;68:349-360.
6. Tihan T, Filippa DA. Coexistence of renal cell carcinoma and malignant lymphoma. A causal relationship or coincidental occurrence. Cancer 1996;77:2325-2331.
7. Begg CB, Zhang, ZF, Sun M, Herr HW, Schantz SP. Methodology for evaluating the incidence of second primary cancers with application to smokingrelated cancers from the Surveillance, Epidemiology, and End Results (SEER) program. Am J Epidemiol 1995;142:653-665.
8. Salloum E, Doria R, Schubert W, Zelterman D, Holford T, Roberts KB, Farber LR, Kiehl RK, Cardinale J, Cooper DL. Second solid tumors in patients with Hodgkin's disease cured after radiation or chemotherapy plus adjuvant low-dose radiation. J Clin Oncol 1996;14:2435-2443.
9. Rabbani F, Grimaldi G, Russo P. Multiple primary malignancies in renal cell carcinoma. J Urol 1998;160:1255-1259.
10. Beisland C, Talleraas O, Bakke A, Norstein J. Multiple primary malignancies in patients with renal cell carcinoma: a national population-based cohort study. BJU International 2006;97:698-702.
11. Matthew JH, Nadia H, Marsha ER, Brenda KE. Cancer statistics, Trends, and Multiple Primary Cancer Analyses from the Surveillance, Epidemiology, and End Result (SEER) Program. TheOncologist 2007;12:20-37.
12. Coleman MP. Multiple primary malignant neoplasms in England and Wales, 1971-1981. Yale J Biol Med 1986;59:517-531.
13. Levi F, Randimbson L, Te VC, Rolland-Portal I, Franceschi S, La Vecchia C. Multiple primary cancers in the Vaud Cancer Registry, Switzerland, 1974-89. Br J Cancer 1993;67:391-395.
14. Tsukuma H, Fujimoto I, Hanai A, Hiyama T, Kitagawa T, Kinoshita N. Incidence of second primary cancers in Osaka residents, Japan, with special reference to cumulative and relative risks. Jpn J Cancer Res 1994;85:339-345.
15. Frodin JE, Ericsson J, Barlow L. Multiple primary malignant tumors in a national cancer registry-reliability of reporting. Acta Oncol 1997;36:465-469.
16. Czene, K. and Hemminki, K. Familial papillary renal cell tumors and subsequent cancers: a nationwide epidemiological study from Sweden. J Urol 2003;169:1271-1275.
17. Kantor AF, McLaughlin JK, Curtis RE, Flannery JT, Fraumeni JF Jr. Risk of second malignancy after cancers of the renal parenchyma, renal pelvis, and ureter. Cancer 1986;58:1158-1161.
18. Greenberg RS, Rustin ED, Clark WS. Risk of genitourinary malignancies after cancer of the prostate. Cancer 1988:61:396-401.
19. Tihan T, Filippa DA. Coexistence of renal cell carcinoma and malignant lymphoma. A causal relationship or coincidental occurrence? Cancer 1996;77:2325-2331.
20. Brumback RA, Gerber JE, Hicks DG, Strauchen JA. Adenocarcinoma of stomach following irradiation and chemotherapy for lymphoma in young patients. Cancer 1984; 54:994-998.
21. Sandler RS, Sandler DP. Radiation-induced cancers of the colon and rectum: assessing the risk. Gastroenterology 1983;84:51-57.
22. Masaki N, Hashimoto T, Ikeda H, Inoue T, Kozuka T. Multiple Primary Malignancies in Patients with Head and Neck Cancer. Jpn. J. Clin. Oncol 1987;17:303-307.
23. Swerdlow AJ, Barber JA, Hudson GV, Cunningham D, Gupta RK, Hancock BW, Horwich A, Lister TA, Linch DC. Risk of second malignancy after Hodgkin& s disease in a collaborative British cohort: the relation to age at treatment. J Clin Oncol 2000;18:498-509.
24. Van Leeuwen FE, Stiggelbout AM, Van den Belt-Dusebout AW, Noyon R, Eliel MR, Van Kerkhoff EH, Delemarre JF, Somers R. Second cancer risk following testicular cancer: a follow-up study of 1,909 patients. J Clin Oncol 1993;11:415-424.